Can a phone call uncover missed cognitive decline? CaringAI’s AAIC data offer an early answer
CaringAI’s phone-based cognitive screening matched clinician scoring in a small study, but larger validation will determine its clinical reach.
Medical Devices & Diagnostics
Pharma & Biotech
Could zervimesine become the first approved treatment for dementia with Lewy bodies psychosis?
Cognition Therapeutics’ FDA alignment gives zervimesine a clearer pivotal path in dementia with Lewy bodies psychosis, a high-need disorder with no approved therapy